Insulin resistance (IR), as a central pathophysiological mechanism of several metabolic diseases (type 1 diabetes mellitus, metabolic syndrome, obesity, polycystic ovary syndrome, etc.)(8–10), refers to the decrease in the body’s sensitivity to insulin, which leads to ineffective glucose uptake and utilization by the target tissues and cells (11). This evidence concerns the gene INS and Insulin resistance.